FDA Application
-
NDC Search Results on Active Ingredient: methotrexate
Click on Active Ingredient to view the label.
Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
---|---|---|---|---|---|
METHOTREXATE SODIUM | 16729-486-36 | Accord Healthcare Inc. | ANDA213343 | HUMAN PRESCRIPTION DRUG | ANDA |
METHOTREXATE SODIUM | 16729-486-01 | Accord Healthcare Inc. | ANDA213343 | HUMAN PRESCRIPTION DRUG | ANDA |
METHOTREXATE | 16729-277-03 | Accord Healthcare, Inc. | ANDA040716 | HUMAN PRESCRIPTION DRUG | ANDA |
METHOTREXATE | 16729-277-30 | Accord Healthcare, Inc. | ANDA040716 | HUMAN PRESCRIPTION DRUG | ANDA |
METHOTREXATE | 16729-277-35 | Accord Healthcare, Inc. | ANDA040716 | HUMAN PRESCRIPTION DRUG | ANDA |
METHOTREXATE SODIUM | 69238-1423-6 | Amneal Pharmaceuticals NY LLC | ANDA210040 | HUMAN PRESCRIPTION DRUG | ANDA |
METHOTREXATE SODIUM | 69238-1423-1 | Amneal Pharmaceuticals NY LLC | ANDA210040 | HUMAN PRESCRIPTION DRUG | ANDA |
METHOTREXATE | 54436-022-03 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-012-01 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-020-02 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-017-01 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-010-04 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-022-04 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-022-02 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-020-01 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-025-04 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-010-02 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-012-02 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-020-04 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-015-01 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-012-03 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-020-03 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-015-02 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-022-01 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-025-02 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-017-02 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-015-03 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-010-01 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-015-04 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-025-03 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
1-30 | 31-60 | 61-90 | 91-120 | 121-150 | 151-170 |
-